Systemic vascular resistance during brief withdrawal of angiotensin converting enzyme inhibition in heart failure

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 62, Issue 4, 2002, Pages 245-254

  Gabrielsen, Anders ^a   Bie, P ^a   Christensen, N J ^a   Frandsen, E ^a   Galatius, S ^a   Pump, B ^a   Sorensen V B ^a   Kastrup, J ^a   Norsk, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Baroreflexes; Blood pressure; Cardiac output; Posture; Sympathetic nervous activity

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; BODY POSTURE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG WITHDRAWAL; ENZYME INHIBITION; HEART EJECTION FRACTION; HEART FAILURE; HORMONE BLOOD LEVEL; HUMAN; MALE; PATIENT POSITIONING; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE; ADRENERGIC SYSTEM; BLOOD PRESSURE; CONGESTIVE HEART FAILURE; DRUG EFFECT; HEART OUTPUT; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSORECEPTOR REFLEX; VASCULAR RESISTANCE; WITHDRAWAL SYNDROME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BAROREFLEX; BLOOD PRESSURE; CARDIAC OUTPUT; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; POSTURE; SUBSTANCE WITHDRAWAL SYNDROME; SYMPATHETIC NERVOUS SYSTEM; VASCULAR RESISTANCE;

EID: 0036315819     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655102760145799     Document Type: Article

References (26)

1. Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure
2. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure
3. Cardiovascular and neuroendocrine responses to water immersion in compensated heart failure
4. Angiotensin II sympathetic activity in patients with congestive heart failure
5. Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm
6. Regulation of peripheral vascular tone in patients with heart failure: Contribution of angiotensin II
7. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure
8. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure
9. Regional blood flow response to orthostasis in patients with congestive heart failure
10. Congestive heart failure: Mechanisms, physiologic derangement, and therapy
11. Cardiocirculatory dynamics in the normal and failing heart
12. A modified photo- and magnetoacoustic multigas analyzer applied in gas exchange measurements
13. Non-invasive measurement of cardiac output in heart failure patients using a new foreign gas rebreathing technique
14. Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age
15. Measurement of angiotensin II in human plasma: Technical modifications and practical experience
16. Lymphocyte norepinephrine and epinephrine, but not plasma catecholamines, predict lymphocyte cAMP production
17. Effects of angiotensin II on muscle sympathetic nerve activity in humans
18. Prostaglandins in severe congestive heart failure. Relation to activation of the renin-angiotensin system and hyponatremia
19. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion
20. Plasma N-terminal atrial natriuretic factor: A predictor of survival in patients with congestive heart failure
21. Atrial natriuretic peptide: A new factor in hormonal control of blood pressure and electrolyte homeostasis
22. Vascular and renal prostaglandins as counter-regulatory systems in heart failure
23. Functional effects of endogenous bradykinin in congestive heart failure
24. Effect of bradykinin on arteries and veins in systemic and pulmonary circulation
25. Prostaglandin E2 in dogs with heart failure: Hemodynamic, hormonal, and renal effects
26. Peripheral hemodynamic effects of captopril in patients with congestive heart failure